The events of "erosion", infection, and inadequate tissue ingrowth are physiological complications, and analysis of the device generally does not assist allergan in determining a probable cause for these events.The physician discarded the device when it was explanted and it is no longer available for return.Therefore, allergan will not receive the device and no analysis or testing will be done.Device labeling addresses the reported event of infection as follows: "adverse reactions are those typically associated with surgically implantable materials, including infection, inflammation, adhesion formation, fistula formation, and extrusion." these events are being reported because medical intervention was required, although device-relatedness has not been established.
|
Healthcare professional reported right side exposure.Upon further investigation, the physician indicated the device was used for inframammary fold support during revision to breast augmentation on (b)(6) 2014.Post implantation on (b)(6) 2015, the patient presented with "erosion" at the incision site.The device was found to show no integration with the patient's tissue, and was completely removed on (b)(6) 2015.The physician indicated the site had become infected, but did not indicate whether the infection occurred before or after the scaffold device was removed.This led to removal and exchange of the concomitant breast implant on (b)(6) 2015.
|